<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 26, 2000
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
Initial Depositor
(Exact name of registrant as specified in its charter)
Biotech HOLDRS(SM) Trust
(Issuer with respect to the receipts)
DELAWARE
(State or other jurisdiction of incorporation)
333-89355
(Commission File Number)
13-5674085
(I.R.S. Employer Identification No.)
250 Vesey Street
New York, New York 10281
(Address of principal executive offices and zip code)
(212) 449-1000
(Registrant's telephone number, including area code)
Page 1 of 5 pages.
The Exhibit Index appears at Page 4.
<PAGE>
Item 5. Other Events
On May 26, 2000, QLT Photo Therapeutics, Inc. changed its name to QLT
Inc.
The share amounts set forth in Exhibit 99 below reflect all previous
stock splits. The stock prices in the tables set forth in Annex A of the base
prospectus will not be adjusted to account for the stock splits.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
(99) Biotech HOLDRS(SM) Trust Prospectus Supplement dated June
30, 2000 to Prospectus dated November 22, 1999.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MERRILL LYNCH, PIERCE, FENNER &
SMITH INCORPORATED
Date: June 30, 2000 By: /s/ STEPHEN G. BODURTHA
---------------------------
Name: Stephen G. Bodurtha
Title: Attorney-in-Fact
3
<PAGE>
EXHIBIT INDEX
Number and Description of Exhibit Sequential
--------------------------------- Page Number
-----------
(99) Biotech HOLDRS(SM) Trust Prospectus Pg. 5
Supplement dated June 30, 2000 to
Prospectus dated November 22, 1999.
4
